No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Retinal Pigment Epithelial Detachment (PED) is a medical condition that affects the retina of the eye. It is caused by fluid accumulation between the retinal pigment epithelium (RPE) and the underlying choroid. PED can lead to vision loss and is a major cause of blindness. Treatment options for PED include laser photocoagulation, photodynamic therapy, and anti-VEGF injections.
Optical treatments for PED are becoming increasingly popular due to their non-invasive nature and the potential for improved outcomes. Optical treatments include optical coherence tomography (OCT), adaptive optics, and optical imaging. These treatments can help to diagnose and monitor PED, as well as provide guidance for treatment.
Companies in the Retinal Pigment Epithelial Detachment market include Carl Zeiss Meditec, Topcon Corporation, Heidelberg Engineering, Optovue, Nidek, and Optos. Show Less Read more
